Accelerating AI Adoption And Precision Medicine Will Empower Computational Breakthroughs
AN
AnalystHighTarget
Not Invested
Consensus Narrative from 10 Analysts
Published
17 Aug 25
Updated
17 Aug 25
AnalystHighTarget's Fair Value
US$33.00
41.2% undervalued intrinsic discount17 Aug
US$19.40
1Y
-5.3%7D
2.9%